OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Metformin: A promising drug for human cancers (Review)
Hongnian Wu, Dan Huang, Hong Zhou, et al.
Oncology Letters (2022) Vol. 24, Iss. 1
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Metformin has anti-inflammatory effects and induces immunometabolic reprogramming via multiple mechanisms in hidradenitis suppurativa
Andreea Petrasca, Róisín Hambly, Niamh Kearney, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 6, pp. 730-740
Open Access | Times Cited: 19

Metformin’s Effects on Cognitive Function from a Biovariance Perspective: A Narrative Review
Dimitrie Chele, Carmen Adella Sîrbu, Marian Mitrică, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 4, pp. 1783-1783
Open Access

Metformin as a booster of cancer immunotherapy
Jutatip Panaampon, Yubin Zhou, Charupong Saengboonmee
International Immunopharmacology (2023) Vol. 121, pp. 110528-110528
Closed Access | Times Cited: 12

Role and regulation of FOXO3a: new insights into breast cancer therapy
Wenqiu Mei, Bingyin Mei, Jing Chang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 4

Potential Role of Phytochemicals as Glucagon-like Peptide 1 Receptor (GLP-1R) Agonists in the Treatment of Diabetes Mellitus
J. O. Abiola, Ayoola Abidemi Oluyemi, Olajumoke Tolulope Idowu, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 6, pp. 736-736
Open Access | Times Cited: 4

The Matrix Reloaded—The Role of the Extracellular Matrix in Cancer
Hans Raskov, Shruti Gaggar, Asma Tajik, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2057-2057
Open Access | Times Cited: 11

PPAR-γ agonist pioglitazone and the risks of malignancy among type2 diabetes mellitus patients
Lai‐Chu See, Chao-Yi Wu, Chung‐Ying Tsai, et al.
Acta Diabetologica (2024)
Closed Access | Times Cited: 3

Doxazosin inhibits vasculogenic mimicry in human non‑small cell lung cancer through inhibition of the VEGF‑A/VE‑cadherin/mTOR/MMP pathway
Jui‐Ling Hsu, Wohn‐Jenn Leu, Lih‐Ching Hsu, et al.
Oncology Letters (2024) Vol. 27, Iss. 4
Open Access | Times Cited: 2

Drug repurposing for cancer
Juni Banerjee, Anand Krishna Tiwari, Shuvomoy Banerjee
Progress in molecular biology and translational science (2024), pp. 123-150
Closed Access | Times Cited: 2

Diabetes and Cancer: A Twisted Bond
Mihai Cosmin Stan, Doru Paul
Oncology Reviews (2024) Vol. 18
Open Access | Times Cited: 2

Unveiling the antitumor synergy between pazopanib and metformin on lung cancer through suppressing p-Akt/ NF-κB/ STAT3/ PD-L1 signal pathway
Fatma Abdallah, Asser I. Ghoneim, Mohammad M. Abd‐Alhaseeb, et al.
Biomedicine & Pharmacotherapy (2024) Vol. 180, pp. 117468-117468
Open Access | Times Cited: 2

A triple-drug combination induces apoptosis in cervical cancer-derived cell lines
Izamary Delgado-Waldo, Carlos Contreras-Romero, Sandra Salazar-Aguilar, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6

Development and validation of a GC-MS method for determination of metformin in normal brain and in glioblastoma tissues
Giorgia Ailuno, Sara Baldassari, Alice Balboni, et al.
Journal of Pharmaceutical and Biomedical Analysis (2023) Vol. 234, pp. 115503-115503
Open Access | Times Cited: 6

Metformin increases 3-hydroxy medium chain fatty acids in patients with type 2 diabetes: a cross-sectional pharmacometabolomic study
Khaled Naja, Najeha Anwardeen, Ahmed Malki, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 1

Mendelian randomization combined with multi-omics explores the relationship between heart failure and cancer
Tian Sun, Na Mei, Yanting Su, et al.
Journal of Cancer (2024) Vol. 15, Iss. 10, pp. 2928-2939
Open Access | Times Cited: 1

An Aging-Related lncRNA Signature Establishing for Breast Cancer Prognosis and Immunotherapy Responsiveness Prediction
Yanshijing Zhou, Zihui Yang, Hong Zeng
Pharmacogenomics and Personalized Medicine (2024) Vol. Volume 17, pp. 251-270
Open Access | Times Cited: 1

Changes in the Sensitivity of MCF-7 and MCF-7/DX Breast Cancer Cells to Cytostatic in the Presence of Metformin
Justyna Płonka, Luiza Żyrek, Małgorzata Latocha
Molecules (2024) Vol. 29, Iss. 15, pp. 3531-3531
Open Access | Times Cited: 1

Unraveling the Genetic and Singaling Landscapes of Pediatric Cancer
Gowrang Kasaba Manjunath, Krishna Veni Ankam, Tikam Chand Dakal, et al.
Pathology - Research and Practice (2024) Vol. 263, pp. 155635-155635
Closed Access | Times Cited: 1

A Retrospective Study on the Role of Metformin in Colorectal Cancer Liver Metastases
Miran Rada, Lucyna Krzywoń, Stephanie Petrillo, et al.
Biomedicines (2023) Vol. 11, Iss. 3, pp. 731-731
Open Access | Times Cited: 4

Depression, Inflammation, and the Moderating Role of Metformin: Results From the Midlife in the United States Study and Sacramento Area Latino Study on Aging
Sumaiyah Syed, Jared Isaac Cortez, Stephanie J. Wilson
Psychosomatic Medicine (2023) Vol. 86, Iss. 5, pp. 473-483
Closed Access | Times Cited: 4

Countermeasure development against space radiation-induced gastrointestinal carcinogenesis: Current and future perspectives
Shubhankar Suman, Albert J. Fornace
Life Sciences in Space Research (2022) Vol. 35, pp. 53-59
Open Access | Times Cited: 7

The Involvement of Hypoxia in the Response of Neuroblastoma Cells to the Exposure of Atorvastatin
Ana Salomé Correia, Lara Marques, Nuno Vale
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3333-3346
Open Access | Times Cited: 3

The potential of metformin nanoformulations for cancer prevention and therapy
Seyyedeh Mina Hejazian, Parnia Pouya, Sepideh Zununi Vahed, et al.
Journal of Drug Delivery Science and Technology (2024) Vol. 101, pp. 106265-106265
Closed Access

Page 1 - Next Page

Scroll to top